本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

快而精医药

42.07
-0.9900-2.30%
盘后42.070.00000.00%19:58 EDT
成交量:89.64万
成交额:3,779.58万
市值:90.92亿
市盈率:110.54
高:42.59
开:42.50
低:41.82
收:43.06
数据加载中...
2025/03/29

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/11/08

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/09/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/30

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/11

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/09

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/07

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/08/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/03/13

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/08

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/03/14

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/02

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/03/05

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/03

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/26

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/22

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/08/03

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/03/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/03

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]